Reference 5 - Concentration-Dependent Bidirectional Modification of Evoked Synaptic Transmission by Gadolinium
NonrulemakingSupporting & Related MaterialFDA-2026-P-6737-0007
Document
Details
The document's own metadata, straight from regulations.gov.
- Posted
- Jun 15, 2026
- Agency
- Food and Drug Administration (FDA)